Keld Danø

27.3k total citations · 6 hit papers
218 papers, 23.8k citations indexed

About

Keld Danø is a scholar working on Cancer Research, Hematology and Oncology. According to data from OpenAlex, Keld Danø has authored 218 papers receiving a total of 23.8k indexed citations (citations by other indexed papers that have themselves been cited), including 176 papers in Cancer Research, 102 papers in Hematology and 81 papers in Oncology. Recurrent topics in Keld Danø's work include Protease and Inhibitor Mechanisms (173 papers), Blood Coagulation and Thrombosis Mechanisms (99 papers) and Peptidase Inhibition and Analysis (73 papers). Keld Danø is often cited by papers focused on Protease and Inhibitor Mechanisms (173 papers), Blood Coagulation and Thrombosis Mechanisms (99 papers) and Peptidase Inhibition and Analysis (73 papers). Keld Danø collaborates with scholars based in Denmark, United States and Italy. Keld Danø's co-authors include Niels Behrendt, Leif R. Lund, Lene Nielsen, J Grøndahl-Hansen, Francesco Blasi, Ebbe Rønne, P.A. Andreasen, Michael Ploug, Lars Skriver and Vincent Ellis and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Keld Danø

215 papers receiving 22.8k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Plasminogen Activators, Tissue Degradation, and Cancer

1985 2.3k citations Keld Danø, P.A. Andreasen et al. profile →
Active outward transport of daunomycin in resistant ehrlich ascites tumor cells

1973 596 citations Keld Danø profile →
Urokinase-type plasminogen activator: proenzyme, receptor, and inhibitors

1987 565 citations Francesco Blasi, Keld Danø et al. profile →
Cloning and expression of the receptor for human urokinase plasminogen activator, a central molecule in cell surface, plasmin dependent proteolysis.

1990 556 citations Maria Vittoria Cubellis, Maria Teresa Masucci et al. profile →
Cellular receptor for urokinase plasminogen activator. Carboxyl-terminal processing and membrane anchoring by glycosyl-phosphatidylinositol

1991 518 citations Michael Ploug, Ebbe Rønne et al. Journal of Biological Chemistry profile →
Fibrinolysis Associated with Oncogenic Transformation

1974 364 citations Keld Danø et al. Journal of Biological Chemistry profile →

Peers

Countries citing papers authored by Keld Danø

Since Specialization

Citations

This map shows the geographic impact of Keld Danø's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keld Danø with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keld Danø more than expected).

Fields of papers citing papers by Keld Danø

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keld Danø. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keld Danø. The network helps show where Keld Danø may publish in the future.

Co-authorship network of co-authors of Keld Danø

This figure shows the co-authorship network connecting the top 25 collaborators of Keld Danø. A scholar is included among the top collaborators of Keld Danø based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keld Danø. Keld Danø is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Urokinase receptor forms in serum from non-small cell lung cancer patients: Relation to prognosis 2011 ·Lung Cancer ·(unknown), Ib Jarle Christensen, Gunilla Høyer‐Hansen, Keld Danø, Helle Pappot, Hendrik Dienemann, Thomas Muley	30
2	Prognostic and predictive value of intact and cleaved forms of the urokinase plasminogen activator receptor in metastatic prostate cancer 2010 ·The Prostate ·(unknown), Klaus Brasso, Peter Iversen, Helle Pappot, Gunilla Høyer‐Hansen, Keld Danø, Ib Jarle Christensen	47
3	Cytogenetic investigations on an Ehrlich ascites tumor, and four sublines resistant to daunomycin, adriamycin, vincristine and vinblastine 2009 ·Hereditas ·Lis Hasholt, Keld Danø	0
4	Systemic administration of anti‐urokinase plasminogen activator receptor monoclonal antibodies induces hepatic fibrin deposition in tissue‐type plasminogen activator deficient mice 2007 ·Journal of Thrombosis and Haemostasis ·Annika Jögi, Jesper Pass, Gunilla Høyer‐Hansen, Leif R. Lund, Boye Schnack Nielsen, Keld Danø, John Rømer	16
5	Stromal cells associated with early invasive foci in human mammary ductal carcinoma in situ coexpress urokinase and urokinase receptor 2007 ·International Journal of Cancer ·Boye Schnack Nielsen, Fritz Rank, Martin Illemann, Leif R. Lund, Keld Danø	79
6	Leading-Edge Myofibroblasts in Human Colon Cancer Express Plasminogen Activator Inhibitor-1 2004 ·American Journal of Clinical Pathology ·Martin Illemann, Ulla Hansen, Hans Jørgen Nielsen, Peter A. Andreasen, Gunilla Høyer‐Hansen, Leif R. Lund, Keld Danø, Boye Schnack Nielsen	5
7	uPARAP/endo180 directs lysosomal delivery and degradation of collagen IV 2003 ·Experimental Cell Research ·Lars Kjøller, Lars H. Engelholm, Maria Høyer-Hansen, Keld Danø, Thomas Bugge, Niels Behrendt	86
8	Urokinase-catalysed cleavage of the urokinase receptor requires an intact glycolipid anchor 2001 ·Biochemical Journal ·Gunilla Høyer‐Hansen, Ulrich Pessara, Arne Holm, Jesper Pass, Ulrich H. Weidle, Keld Danø, Niels Behrendt	52
9	Different mechanisms are involved in the antibody mediated inhibition of ligand binding to the urokinase receptor: a study based on biosensor technology 1999 ·Journal of Immunological Methods ·Karin List, Gunilla Høyer‐Hansen, Ebbe Rønne, Keld Danø, Niels Behrendt	35
10	Elevated plasma levels of urokinase plasminogen activator receptor in non-small cell lung cancer patients 1997 ·European Journal of Cancer ·Helle Pappot, Gunilla Høyer‐Hansen, Ebbe Rønne, Heine H. Hansen, Nils Brünner, Keld Danø, J Grøndahl-Hansen	67
11	Domain Interplay in the Urokinase Receptor 1996 ·Journal of Biological Chemistry ·Niels Behrendt, Ebbe Rønne, Keld Danø	91
12	Stromal Cell Expression of Components ofMatrix-Degrading Protease Systems inHuman Cancer 1996 ·PubMed ·Robert E. Hewitt, Keld Danø	69
13	Urokinase plasminogen activator (uPA) and its type 1 inhibitor (PAI-1): Regulators of proteolysis during cancer invasion and prognostic parameters in Breast cancer 1994 ·Cancer treatment and research ·Nils Brünner, Charles Pyke, (unknown), John Rømer, J Grøndahl-Hansen, Keld Danø	27
14	Expression of uPA and its receptor by both neoplastic and stromal cells during xenograft invasion 1994 ·International Journal of Cancer ·John Rømer, Charles Pyke, Leif R. Lund, Jens Eriksen, Peter Kristensen, Ebbe Rønne, Gunilla Høyer‐Hansen, Keld Danø, Nils Brünner	48
15	[13] Cellular receptor for urokinase-type plasminogen activator: Protein structure 1993 ·Methods in enzymology on CD-ROM/Methods in enzymology ·Niels Behrendt, Michael Ploug, Ebbe Rønne, Gunilla Høyer‐Hansen, Keld Danø	30
16	A soluble form of the glycolipid‐anchored receptor for urokinase‐type plasminogen activator is secreted from peripheral blood leukocytes from patients with paroxysmal nocturnal hemoglobinuria 1992 ·European Journal of Biochemistry ·Michael Ploug, Jens Eriksen, Torben Plesner, Niels Ebbe Hansen, Keld Danø	65
17	Complementation between urokinase-producing and receptor-producing cells in extracellular matrix degradation. 1991 ·PubMed ·Paul H.A. Quax, Nina Marie Pedersen, Maria Teresa Masucci, (unknown), Keld Danø, Jan H. Verheijen, Francesco Blasi	80
18	The urokinase receptor and regulation of cell surface plasminogen activation 1990 ·PubMed ·Francesco Blasi, Maria Vittoria Cubellis, Maria Teresa Masucci, Lisbeth Birk Møller, David P. Olson, Nina Marie Pedersen, Niels Behrendt, Vincent Ellis, Leif R. Lund, Michael Ploug, Ebbe Rønne, Keld Danø	67
19	The regulatory region of the human plasminogen activator inhibitor type-1 (PAI-1) gene 1988 ·Nucleic Acids Research ·Andrea Riccio, Leif R. Lund, (unknown), Andrea Lania, (unknown), Keld Danø, Francesco Blasi	71
20	cDNA cloning of human plasminogen activator-inhibitor from endothelial cells. 1986 ·Journal of Clinical Investigation ·David Ginsburg, R Zeheb, Angela Yang, (unknown), P.A. Andreasen, Lene Nielsen, Keld Danø, R V Lebo, Thomas Gelehrter	303

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact